<
Four ministries and commissions jointly issued a document: Vigorously promote pharmaceutical research and development outsourcing and production outsourcing services
Release time: 2018-06-09 & nbsp & nbsp & nbsp Source: Anonymous

A few days ago,National Development and Reform Commission、Ministry of Industry and Information Technology、Health and Health Committee、The State Drug Administration jointly issued the "Notice on the Organization of the Construction of R & D and Production Service Platform Construction of Biomedical Contracts" (hereinafter referred to as the "Notice"),Four stake sports betting appministries intend to organize the implementation of the implementation of biomedical contract research and development and production service platform construction during the "13th Five -Year Plan" period。This special will focus on supporting biomedical contract research and development services,Support superior enterprise in pharmaceutical research、Pre -clinical safety evaluation、New drug clinical research and other subdivided field construction contract research and development service platform。This project will also focus on supporting biomedical contract production services,Support the development and industrialization of innovative drug production technology、Construction of contract production and service platforms such as large -scale commission processing and processing of listed drugs。

This special supports develops the development of drugs and outsourcing (foundry) services for drugs,Support new drug development,Create a batch of strong comprehensive strength、Professional contract research and development and production service enterprises with international competitiveness,and accelerate the formation of a group of world -class biomedical industry agglomerations。The reform of the pharmaceutical industry is extremely rapid,Drug review reform,Consistency Evaluation,National Science and Technology stake betting appSpecial and Key R & D Plan,Innovative products、Clinical urgent need of products and fast batch listing for breaking import monopoly products,Clinical trials liberalized ... One after another reform policy is continuously released、Land。This time,The key point is to point the listing license holder system that unlocked the research and development and production links。

Previous,The country has launched a drug listing license holder system in the drug field,Pilot、Land,Get certain results。This special is to further implement the obstacle of the drug listing license holder system,Putting the road,To promote the structural reform of the supply side of the drug。The construction project set in the notice is only pointing to the field of drug research and development and production,After the launch of the holder system of the drug listing permit,System of medical device registrar systems similar to it has also begun pilot。The State Council posted before,To further expand the pilot range。According to the medicine first、Industry practice of medical device subsequent follow -up,Similar support for research and development outsourcing and production outsourcing construction in the field of medical device in the field of medical equipment。

According to "Notice",Central Finance will directly give the special construction strong Stake Sports Bettingfunding support。It is declared by an enterprise、Eligible projects in the review,A single project's national subsidy funds in principle are about 30%of the total investment of the project,The highest amount of 100 million yuan。The application project of pharmaceutical enterprises must also meet certain basic standards and conditions,The amount of R & D service contract in 2017 must exceed 200 million yuan,The amount of production service contracts for outsourcing companies in 2017 must exceed 300 million yuan。

Implementation of this special construction,It is a great benefit to existing advantageous enterprises in the field of R & D and production outsourcing,helps reduce costs、Expansion scale,Further enhanced competitiveness,Become a leading company in the industry。and the implementation of this special,It will also accelerate the landing of the listing holder system in the industry,Accelerate the change of the industry's existing R & D and production pattern,Create the accelerated listing of innovative products,Exit and eliminate a number of low -end competition companies,Improve the professional and large -scale production capacity of Chinese pharmaceutical companies,and improving China's competitiveness in the development of stake online sports bettingnew drugs around the world。